Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70

View ORCID ProfileSA Kemp, WT Harvey, RP Datir, DA Collier, IATM Ferreira, AM Carabelli, DL Robertson, View ORCID ProfileRK Gupta
doi: https://doi.org/10.1101/2020.12.14.422555
SA Kemp
1Division of Infection and Immunity, University College London, London, UK.
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
3Department of Medicine, University of Cambridge, Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for SA Kemp
WT Harvey
4MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RP Datir
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA Collier
1Division of Infection and Immunity, University College London, London, UK.
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
3Department of Medicine, University of Cambridge, Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IATM Ferreira
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
3Department of Medicine, University of Cambridge, Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AM Carabelli
3Department of Medicine, University of Cambridge, Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DL Robertson
4MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.
5Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RK Gupta
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
3Department of Medicine, University of Cambridge, Cambridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for RK Gupta
  • For correspondence: rkg20@cam.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

SARS-CoV-2 Spike amino acid replacements in the receptor binding domain (RBD) occur relatively frequently and some have a consequence for immune recognition. Here we report recurrent emergence and significant onward transmission of a six-nucleotide deletion in the S gene, which results in loss of two amino acids: H69 and V70. Of particular note this deletion, ΔH69/V70, often co-occurs with the receptor binding motif amino acid replacements N501Y, N439K and Y453F. One of the ΔH69/V70+ N501Y lineages, B.1.1.7, is comprised of over 1400 SARS-CoV-2 genome sequences from the UK and includes eight S gene mutations: RBD (N501Y and A570D), S1 (ΔH69/V70 and Δ144/145) and S2 (P681H, T716I, S982A and D1118H). Some of these mutations have possibly arisen as a result of the virus evolving from immune selection pressure in infected individuals and possibly only one chronic infection in the case of lineage B.1.1.7. We find the ΔH69/V70 enhances viral infectivity, indicating its effect on virus fitness is independent to the N501Y RBM change. Enhanced surveillance for the ΔH69/V70 deletion with and without RBD mutations should be considered as a priority. Such “permissive” mutations have the potential to enhance the ability of SARS-CoV-2 to generate vaccine escape variants that would have otherwise significantly reduced viral fitness.

Competing Interest Statement

RKG has received consulting fees from UMOVIS lab, Gilead Sciences and ViiV Healthcare, and a research grant from InvisiSmart Technologies.

Footnotes

  • Author affiliation has been corrected

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 21, 2020.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
SA Kemp, WT Harvey, RP Datir, DA Collier, IATM Ferreira, AM Carabelli, DL Robertson, RK Gupta
bioRxiv 2020.12.14.422555; doi: https://doi.org/10.1101/2020.12.14.422555
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70
SA Kemp, WT Harvey, RP Datir, DA Collier, IATM Ferreira, AM Carabelli, DL Robertson, RK Gupta
bioRxiv 2020.12.14.422555; doi: https://doi.org/10.1101/2020.12.14.422555

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (2647)
  • Biochemistry (5271)
  • Bioengineering (3682)
  • Bioinformatics (15799)
  • Biophysics (7261)
  • Cancer Biology (5629)
  • Cell Biology (8102)
  • Clinical Trials (138)
  • Developmental Biology (4769)
  • Ecology (7524)
  • Epidemiology (2059)
  • Evolutionary Biology (10588)
  • Genetics (7734)
  • Genomics (10138)
  • Immunology (5199)
  • Microbiology (13921)
  • Molecular Biology (5392)
  • Neuroscience (30805)
  • Paleontology (215)
  • Pathology (879)
  • Pharmacology and Toxicology (1525)
  • Physiology (2256)
  • Plant Biology (5026)
  • Scientific Communication and Education (1042)
  • Synthetic Biology (1389)
  • Systems Biology (4150)
  • Zoology (812)